RTGNOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31

RetinalGenix Technologies Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026

$3.99+0.00 (0.00%)

Close on Oct 16, 2026

Market cap: $75.04M
P/E (TTM): –
Dividend yield: –

Earnings

Quarterly results announced on Form 8-K, Item 2.02

No earnings releases found

RetinalGenix Technologies has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.

Press releases

Announcements RetinalGenix Technologies filed with the SEC

Dec 4, 2023, 9:46 AM ET
Technologies Inc. Announces Hiring of Interim CFO Press Release | 12/01/2023
Executive or director change · Other events · EX-99.1 to Form 8-K
Jul 7, 2022, 9:24 AM ET
TECHNOLOGIES, INC. ACQUIRES DNA/GPS INC.
Material agreement · Acquisition or disposition completed · Unregistered share sale · Other events · EX-99.1 to Form 8-K